medigraphic.com
ISSN 0016-3813 (Print)

2015, Number 4

<< Back Next >>

Gac Med Mex 2015; 151 (4)

Evaluation of the results of percutaneous closure by means of the Amplatzer device in pediatric patients with intra-auricular communication (IAC)

Delgadillo-Pérez S, Torres-Martel JM, Barrera LJC

Language: Spanish
References: 25
Page: 465-471
PDF size: 244.95 Kb.


ABSTRACT

Objective: To describe the results of percutaneous closure by means of the Amplatzer Septal Occluder (ASO) device in pediatric patients with intra-auricular communication (IAC). Materials and Methods: Descriptive transversal study in patients submitted to percutaneous closure of IAC from March 2005 to March 2013. Patients aged ‹ 16 years, weight › 6 kg, IAC type ostium segundum, and patent foramen ovale, with border separations borders › 5 mm, and absence of coexisting pathology were included in the study. We excluded from the study children with severe pulmonary blood pressure/arterial hypertension. Descriptive statistics with the SPSS v. 20.0 statistical software package. Results: We included in the study 28 patients, feminine gender (n = 19, 68%), median age = 8 years (range, 4-14), weight 30.7 kg (range, 15-69). New York Heart Association (NYHA) functional class I (n = 21, 75%), II (n = 7, 25%). Median IAC size, 15.50 mm (range, 5-25), and a median ASO size of 17.54 mm (range, 8-28). After ASO placement, 100% presented NYHA I at one month, cardiac murmur (n = 2, 7.1%), cessation of cardiac murmur at month 6 (n = 28, 100%), without evidence of arrhythmias at one month 100%, residual short circuit at 24 hours (n = 4, 14%), complete occlusion at month 6 (n = 28, 100%), normalization size of VD, and cessation of tricuspid insufficiency 100% at one year. Complications included minimal bleeding during the procedure (n = 2, 7%), transitory cephalea (n = 5, 18%), and dysautonomia (n = 1, 4%). Conclusion: Percutaneous closure of IAC of children fitted with the ASO device is safe and exhibits good results.


REFERENCES

  1. Samanek M. Congenital heart malformations: prevalence, severity, survival and quality of life. Cardiol Young. 2000;10(3):179-85.

  2. McDaniel NL. Ventricular and atrial defects. Pediatr Rev. 2001;22(8):265-70.

  3. Calderón-Colmenero J, Cervantes-Salazar JL, Curi-Curi PJ, Ramírez-Marroquín S. [Congenital heart disease in Mexico. Regionalization proposal]. Arch Cardiol Mex. 2010;80(2):133-40.

  4. Venegas C, Peña R, Lozano R, Kofman S, Queipo G. Mortalidad por defectos al nacimiento. Bol Med Hosp Infant Mex. 2005;62:294-304.

  5. Salazar J, Cay D, Diarte de M, et al. Cierre percutáneo de comunicación auricular con dispositivo Amplatzer [Informe] / Cardiología Pediátrica, Hospital Universitario Miguel Servet. Federación Argentina de Cardiología: Zaragoza (España); 2003.

  6. Sadlher. Sistema cardiovascular. Embriología médica con orientación clínica. 8.a ed. México: Editorial Médica Panamericana; 2002.

  7. Park M. Cardiopatías congénitas específicas: lesiones con cortocircuito de izquierda a derecha. Cardiología. 5.a ed. México: Editorial Elsevier Mosby; 2008.

  8. Munayer-Calderón JE, Aldana-Pérez T, Carpio-Hernández JC, et al. [Percutaneous closure of inter-atrial communication with the Amplatzer device. Experience with 42 cases]. Arch Cardiol Mex. 2009;79(2):104-6.

  9. Knepp MD, Rocchini AP, Lloyd TR, Aiyagari RM. Long-term follow up of secundum atrial septal deffect closure with the Amplatzer septal occluder. Congenit Heart Dis. 2010;5(1):32-7.

  10. Chiesa S, Glúdice J, Morales J, Gambetta J, Peluffo C, Duhagón P. Diez años de experiencia en el cierre percutáneo de la comunicación interauricular y el ductus arterioso persistente. Rer Urug Cardiol. 2008;23(1): 5-14.

  11. Tomar M, Khatri S, Radhakrishnan S, Shrivastava S. Intermediate and long term followup of percutaneous device clossure of fossa ovalis atrial septal defect by the Amplatzer septal occluder in a cohort of 529 patients. Ann Pediatr Cardiol. 2011;4(1):22-7.

  12. Huang T, Lee C, Hsieh K. Transcatheter Closure of Atrial Septal Defects with the Amplatzer Septal Occluder Clinical Results. Acta Cardiol Sin. 2004;20:223-8.

  13. Masura J, Lange P, Wilkinson J, et al. International multicenter trial of atrial septal catheter closure using the Amplatzer Septa Occluder. Initial results. J Am Coll Cardiol. 2005;45:57-9.

  14. Mathewson J, Bichell D, Rothman A, Ing F. Absent posteroinferior and anterosuperior atrial septal defect rims: factors affecting nonsurgical closure of large secundum defects using the Amplatzer occluder. Am Soc Ecocardiography. 2004;17(1):62-4.

  15. Zabala Argüelles JI, García E, Zunzunegui Martínez JL, et al. [Percutaneous closure of atrial septal defects: midterm results of a new therapeutic strategy]. Rev Esp Cardiol. 2000;53(1):21-6.

  16. Fernández Ruiz A, J Del Cerro Marín M, Rubio Vidal D, C Castro Gussoni M, Moreno Granados F. [Percutaneous closure of atrial septal defect with the Amplatz device: initial result and mid-term follow-up]. Rev Esp Cardiol. 2001;54(10):1190-6.

  17. Ebeid MR. Percutaneous catheter closure of secundum atrial septal defects: a review. J Invasive Cardiol. 2002;14(1):25-31.

  18. King T, Sandra L, Thompson R, Steiner C, Millis N. Secudum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA. 1976;235(23):2506-9.

  19. Everett AD, Jennings J, Sibinga E, et al. Community use of amplatzer atrial septal defect occluder: results of the multicenter MAGIC atrial septal defect study. Pediatr Cardiol. 2009;30(3):240-7.

  20. Carillo R, Zárate V. Comunicación interauricular tipo ostium secundum con tratamiento percutáneo mediante Amplatzer. Med Int Mex. 2011; 27(5):485-91.

  21. Bialkowski J, Kusa J, Szkutnik M, et al. [Percutaneous catheter closure of atrial septal defect. Short-term and mid-term results]. Rev Esp Cardiol. 2003;56(4):383-8.

  22. Zabala C. Tratamiento con los oclusores Amplatzer de los defectos septales. Arch Cardiol Mex. 2003;73(1):158-62.

  23. Parra-Bravo R, Cruz-Ramírez A, Rebolledo-Pineda V, et al. Transcatheter closure of patent ductus arteriosus using the amplatzer duct occluder in infants under 1 year of age. Rev Esp Cardio. 2009;62(8):867-74.

  24. Roel V. Cierre percutáneo de la orejuela de la auricula izquierda en la prevención de complicaciones tromboembólicas asociadas a fibrilación auricular: utilidad e indicación actual. Rev CONAREC. 2013; 29(119):79-91.

  25. Dardas PS, Ninios VN, Mezilis NE, Tsikaderis DD, Thanopoulos VD. Percutaneous closure of atrial septal defects: immediate and mid-term results. Hellenic J Cardiol. 2010;51(2):104-12.




2020     |     www.medigraphic.com